ARIAD Pharmaceuticals (ARIA) Target Lifted at Jefferies on Iclusig Re-Entry
Tweet Send to a Friend
Jefferies analyst Eun K. Yang, Ph.D raised his price target on ARIAD Pharmaceuticals (NASDAQ: ARIA) from $4 to $7 but ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
